🇺🇸 FDA
Patent

US 10829529

Compositions and methods for delivering CFTR polypeptides

granted A61KA61K38/1709A61K48/0075

Quick answer

US patent 10829529 (Compositions and methods for delivering CFTR polypeptides) held by Krystal Biotech, Inc. expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Krystal Biotech, Inc.
Grant date
Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/1709, A61K48/0075, A61K9/0073, A61K9/0075